Author

Zhiyuan Rong

Institutions: Shenyang Medical College, Harbin Medical University, Second Affiliated Hospital of Harbin Medical University

Observed institutions: Shenyang Medical College, Harbin Medical University, Second Affiliated Hospital of Harbin Medical University

ORCID: 0009-0009-4733-460X

Observed ORCID: 0009-0009-4733-460X

OpenAlex ID: A5066015672

Identification of a PANoptosis-related Gene Signature for Predicting the Prognosis, Tumor Microenvironment and Therapy Response in Breast Cancer

2023 · Tianshui Yu, Weilun Cheng, et al. · Journal of Cancer · 17

PDF

BPIFB1 promotes metastasis of hormone receptor‐positive breast cancer via inducing macrophage M2 ‐like polarization

2023 · Anbang Hu, Yansong Liu, et al. · Cancer Science · 15

Inhibition of lncRNA PCAT19 promotes breast cancer proliferation

2023 · Jianyuan Feng, Jiarui Zhang, et al. · Cancer Medicine · 13

PDF

Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database

2024 · Yuhang Shang, Xuelian Wang, et al. · Breast Cancer · 11

PDF

Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer

2024 · Yansong Liu, Mingcui Li, et al. · Cancer Immunology Immunotherapy · 10

Construction of an immunogenic cell death-based risk score prognosis model in breast cancer

2022 · Yanling Li, Jianyuan Feng, et al. · Frontiers in Genetics · 10

Correlation Between the Prognostic Nutritional Index and Breast Cancer in U.S. Adults: NHANES 2001–2018

2025 · Zhiyuan Rong, Jiangwei Liu, et al. · Nutrition and Cancer · 3

Integrated Single-Cell and Bulk RNA Sequencing Identifies SERPING1 as a Biomarker of Immune Infiltration and Prognosis in Triple-Negative Breast Cancer

2026 · Yuhang Shang, Runze Guo, et al. · Frontiers in Bioscience-Landmark · 2

Survival outcomes of neoadjuvant versus adjuvant therapy in patients with T1c, node‐negative, human epidermal growth factor receptor 2–positive breast cancer: A Surveillance, Epidemiology, and End Results population‐based study

2024 · Xuelian Wang, Yuhang Shang, et al. · Cancer · 2

PDF

CHST4 associates with high-abundance immune infiltration in hormone receptor–positive breast cancer

2024 · Yansong Liu, Anbang Hu, et al. · Journal of Leukocyte Biology · 2

Listeria monocytogenes promotes breast cancer proliferation and enhances the survival rate of circulating breast cancer cells

2023 · Yunqiang Duan, Fei Ma, et al. · Research Square · 2

PDF

Breast cancer burden among women of reproductive age in China, Japan, and South Korea, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021

2026 · Zhiyuan Rong · International Journal of Clinical Oncology · 1

Integrated single-cell and bulk RNA sequencing identifies SERPING1 as an immune infiltration regulator and therapeutic target in Triple-negative breast cancer

2025 · Yuhang Shang, Jiangwei Liu, et al. · Research Square · 1

PDF

Clinical Radiologic Analysis of 2964 Papillary Breast Lesions

2024 · Hanyu Zhang, Anbang Hu, et al. · The Breast Journal · 1

PDF

Childhood famine exposure and the risk of gastrointestinal diseases in old individuals: a retrospective cohort analysis using the CHARLS database

2026 · Qingquan Yang, Zhiyuan Rong · BMC Public Health

Identification of a super enhancer associated gene signature for the prognosis prediction and regulatory mechanism exploration in breast cancer

2025 · Mingcui Li, Zhengbo Fang, et al. · Scientific Reports

PDF

Works count: 16

Citation count: 90

H-index: 6

I10-index: 6